Active ingredients: rivastigmine
What it is used for
APO-RIVASTIGMINE is indicated for the treatment of patients with mild to moderate dementia of the Alzheimer's type.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Circular 5cm2 transdermal patch, tri-layer adhesive matrix, translucent white backing film labelled with "Rivastigmine 4.6 mg/24 h"
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient rivastigmine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems